Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis

Multiple Sclerosis International(2022)10.1155/2022/9388813Source: DataRank Database

Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis is a research paper published in Multiple Sclerosis International (2022). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.20)OA: hybridTopics (20)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Shakiba Houshi ORCID,Erfan Sadeghi ORCID,Mozhgan Sadat Hashemi ORCID,Ghasem Pishgahi ORCID,Sara Bagherieh ORCID

Live enrichment

PubMed:36187599 PMC:PMC9519336 OpenAlex:https://openalex.org/W4296710375

Chugai

Biogen

Genentech

PCORI

MedImmune

National Institutes of Health

FWCI

1.20

Citation Percentile

0.7%

Influential Citations

Citation Trend

2021

2022

2023

2024

2025

hybridLicense: cc-by

journalhttps://downloads.hindawi.com/journals/msi/2022/9388813.pdf

HYBRIDhttps://downloads.hindawi.com/journals/msi/2022/9388813.pdf

publisherhttps://downloads.hindawi.com/journals/msi/2022/9388813.pdf

publisherhttp://downloads.hindawi.com/journals/msi/2022/9388813.pdf

publisherhttp://downloads.hindawi.com/journals/msi/2022/9388813.xml

Fields of Study

Multiple Sclerosis Research StudiesSARS-CoV-2 and COVID-19 ResearchPeripheral Neuropathies and DisordersMedicine

Keywords

MedicineMultiple sclerosisMeta-analysisCoronavirus disease 2019 (COVID-19)Disease2019-20 coronavirus outbreakMEDLINESevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BioinformaticsAssociation (psychology)Internal medicineVirologyImmunologyInfectious disease (medical specialty)OutbreakBiology

Sustainable Development Goals

SDG 0: Good health and well-being